Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
12/2003
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/30/2003US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide;
12/25/2003US20030236304 Fluorobenzamides and uses thereof
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030235612 Compounds and compositions for delivering active agents
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003106404A1 Use of alkylamidomandelates as flavourings
12/24/2003WO2003106403A1 Carboxamides derivatives
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2003106380A2 Fluorobenzamides
12/24/2003WO2003105776A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
12/24/2003WO2002090356A3 Method for the production of zolpidem
12/24/2003CN1463266A Binaphthol derivative and method for producing same
12/24/2003CN1463264A Method for producing aromatic compound dimer
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489249A1 Carboxamides derivatives
12/24/2003CA2489247A1 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667341 Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters; anticancer agents, hemological disorders, and inherited metabolic disorders
12/18/2003WO2003104318A1 Conversion products of mixtures of long-chained fatty acids and aliphatic diamines, and the use thereof
12/18/2003WO2003074449A3 Multi-substitued selective androgen receptor modulators and methods of use thereof
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003WO2003048079A3 Method for the arylation of olefins
12/18/2003WO2003045933A3 Preparation and use of gamma-butyrolactones as cross-linking agents
12/18/2003US20030232891 For therapy of pain
12/18/2003US20030232883 N-acylamino benzyl ether derivatives
12/18/2003US20030232823 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
12/18/2003US20030232811 Anthranilic acid derivative
12/18/2003US20030232792 Useful for male contraception, treatment of a variety of hormone-related conditions such as sexual disorders, prostate cancer
12/18/2003US20030232012 For use as in vivo contrast media in nuclear spin tomography (MRT), as blood-pool agents and as lymphographic agents
12/17/2003EP1370671A1 Processes for enhanced production of pantothenate
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370517A1 Gelling agents or thickeners
12/17/2003EP1370515A2 Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
12/17/2003EP1370510A2 Hiv integrase inhibitors
12/17/2003EP1370335A1 Azeotropic distillation process for producing organic acids or organic acid amides
12/17/2003EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1278718B1 Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens
12/17/2003EP1109805B1 Inhibitors of bacterial nad synthetase
12/16/2003US6664421 Process for preparing zolpidem
12/16/2003US6664411 Heterocyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
12/16/2003US6664291 Malonamic acids and derivatives thereof as thyroid receptor ligands
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/16/2003US6663898 Carbon-substituted diketopiperazine delivery systems
12/16/2003US6663887 Compounds and compositions for delivering active agents
12/11/2003WO2003101945A1 Ligands that are inhibitors of the rar receptors
12/11/2003WO2003101941A2 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2003016923A3 Hydroxypyridonate and hydroxypyrimidinone chelating agents
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP1368020A2 Method for identifying maxi-k channel blockers
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/10/2003CN1130124C Fungicidal mixtures
12/09/2003US6660879 Use of the compound in clinical conditions associated with insulin resistance.
12/09/2003US6660756 Protease inhibitors; sexual disorders
12/09/2003US6660755 Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099766A1 (2s)-2-ethylphenylpropionic acid derivative
12/04/2003WO2003099763A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
12/04/2003WO2003099202A2 Beta-secretase inhibitors
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003US20030225302 Aromatic amides, their preparation process and their use as pesticides
12/04/2003US20030225099 E.g., 1-(phenylethyl)-(2-(6-(2-pyridin-2-ylethylcarbamoyl)-pyridin-2 -yl)benzyl)carbamate; use as antiarrhythmic active compounds
12/04/2003US20030225091 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/03/2003EP1367053A1 Process for producing optically active n-aryl-1-amino-2-propanol derivatives
12/03/2003EP1366018A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
12/03/2003CN1460100A Compounds and compositions for delivering active agents
12/03/2003CN1460098A Activator for endogenetic pathway of coagulation and their use for exploring anomalies of coagulation
12/03/2003CN1460097A NF-kB inhibitor containing substituted benzoic acid derivative as active ingredient
12/03/2003CN1129428C Endothelin receptor antagonists
12/02/2003US6657083 5-acylamino-2-amino-4-substituted-phenol compounds and method of using them
12/02/2003US6657069 Reacting 6-aminocarbonylmethyl-4H-2,3- dioxin-4-one compound with alcohol or water to produce 3-oxopentanedicarboxylic acid amide esters; decyclization
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656712 Method for immobilizing and/or crystallizing biological macromolecules on carbon nanotubes and uses
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
11/2003
11/27/2003WO2003097568A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220496 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate
11/27/2003US20030220402 Secondary carbocyclic amides such as 2-(4-(2-naphthyloxy)-benzamido)benzoic acid methyl ester, used as anticarcinogenic agents
11/25/2003US6653348 Antiinflammatory agent for humans
11/25/2003US6653309 Binding ligands
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/20/2003WO2002070463A8 Gelling agents or thickeners
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216593 Reacting salicylic acid with alcohol in presence of an acid; then an amine, or anhydrous ammonia; alkylation a salicylamide
11/20/2003US20030216589 Amino acids which deliver active agents to selected biological systems in increased or improved bioavailability
11/20/2003US20030216469 Cyclic amino acid derivatives useful as pharmaceutical agents
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 157